申请人:American Cyanamid Company
公开号:US05550257A1
公开(公告)日:1996-08-27
This disclosure describes novel substituted oxotremorine derivatives of formula I having nitrogen, oxygen or sulfur groups and the prodrug forms of these derivatives. The compounds have cholinergic activity. Also disclosed are methods for treating diseases of the central nervous system in mammals employing the compounds, pharmaceutical preparations containing the compounds and the processes for the production of the compounds. ##STR1##
这份披露描述了具有氮、氧或硫基团的新型替代氧托莫林衍生物(化学式I),以及这些衍生物的前药形式。这些化合物具有胆碱能活性。还披露了利用这些化合物治疗哺乳动物中枢神经系统疾病的方法,含有这些化合物的药物制剂,以及这些化合物的生产过程。